On March 13, 2026, the National Medical Products Administration gave the green light to the world's first invasive brain-computer interface medical device—the Implantable Brain-Computer Interface Hand Movement Function Compensation System (dubbed the NEO System)—for commercial distribution. This compact system, no larger than a coin, is implanted extradurally in the brain via minimally invasive surgery. It is capable of capturing and interpreting brain signals, enabling patients with hand movement impairments due to spinal cord injuries to control pneumatic gloves using their 'thoughts' and perform actions like grasping and picking up objects. Developed by NeuroXess Medical Technology (Shanghai) Co., Ltd., the NEO System has undergone multi-center confirmatory clinical trials to substantiate its safety and effectiveness, boasting a cumulative safe implantation period of nearly 8,000 days. Three months after surgery, the subjects exhibited a 100% brain-computer interface-assisted grasping response rate, marking a significant enhancement in patients' quality of life.